These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38906237)

  • 1. Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling.
    Zhan G; Wang X; Wang X; Li J; Tang Y; Bi H; Yang X; Xia Y
    Eur J Pharmacol; 2024 Sep; 978():176712. PubMed ID: 38906237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.
    Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL
    Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
    Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Xu B; Xu Y; Ren W; Meng S; Hong T; Cao Z; Xiao X; Guo X; Yu L; Zhao J; Wang H
    Food Funct; 2024 Sep; 15(18):9165-9175. PubMed ID: 39157962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
    Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
    Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin I
    Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G
    Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na
    Uthman L; Baartscheer A; Bleijlevens B; Schumacher CA; Fiolet JWT; Koeman A; Jancev M; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
    Diabetologia; 2018 Mar; 61(3):722-726. PubMed ID: 29197997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
    Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
    Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.
    Trum M; Riechel J; Schollmeier E; Lebek S; Hegner P; Reuthner K; Heers S; Keller K; Wester M; Klatt S; Hamdani N; Provaznik Z; Schmid C; Maier L; Arzt M; Wagner S
    Cardiovasc Res; 2024 Jul; 120(9):999-1010. PubMed ID: 38728438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis.
    Cheng TY; Chen YC; Li SJ; Lin FJ; Lu YY; Lee TI; Lee TW; Higa S; Kao YH; Chen YJ
    Transl Res; 2024 Jun; 268():1-12. PubMed ID: 38244770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes.
    Zou T; Chen Q; Chen C; Liu G; Ling Y; Pang Y; Xu Y; Cheng K; Zhu W; Wang RX; Qian LL; Ge J
    J Thorac Dis; 2022 Jun; 14(6):2187-2200. PubMed ID: 35813708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
    Jiang XX; Zhang R; Wang HS
    Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
    Cao F; Li Z; Ding WM; Yan L; Zhao QY
    Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts.
    Yuan Y; Zhang H; Xia E; Zhao X; Gao Q; Mu H; Liu X; Tian Y; Liu L; Shen Q; Sheng L
    Biomolecules; 2024 Aug; 14(9):. PubMed ID: 39334820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy.
    Yang Z; Li T; Xian J; Chen J; Huang Y; Zhang Q; Lin X; Lu H; Lin Y
    FASEB J; 2022 Jul; 36(7):e22410. PubMed ID: 35713937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.
    Aonuma K; Xu D; Murakoshi N; Tajiri K; Okabe Y; Yuan Z; Li S; Murakata Y; Tominaga K; Nogami A; Aonuma K; Ieda M; Isoda H
    Clin Sci (Lond); 2022 Dec; 136(24):1831-1849. PubMed ID: 36540030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.